Skip to content
HowShorted

Omeros Corporation short interest in 2023

In 2023, Omeros Corporation's disclosed short interest ran from 13.59% of shares outstanding on 13 Jan 2023 to 20.62% on 29 Dec 2023, a change of +7.03 percentage points. The year's high was 20.91% on 13 Oct 2023 and its low 11.89% on 15 Feb 2023, averaging 17.03% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.78 days on 14 Jul 2023. Full history: Omeros Corporation.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Omeros Corporation in 2023

2023 in figures

Start of year
13.59% (13 Jan 2023)
End of year
20.62% (29 Dec 2023)
Change
+7.03 pp
High
20.91% (13 Oct 2023)
Low
11.89% (15 Feb 2023)
Average
17.03%
Highest days to cover
37.78 (14 Jul 2023)
SEC filings marked
9

Every report in 2023

Omeros Corporation short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202313.59%22.24
31 Jan 202313.66%24.35
15 Feb 202311.89%2.15results (8-K)
28 Feb 202312.37%18.99
15 Mar 202313.45%23.8510-K filed, results (8-K)
31 Mar 202314.22%27.91
14 Apr 202314.37%17.53
28 Apr 202314.97%15.55
15 May 202314.45%19.4010-Q filed, results (8-K)
31 May 202314.62%15.36
15 Jun 202315.57%15.10
30 Jun 202318.34%7.94
14 Jul 202318.42%37.78
31 Jul 202318.10%21.95
15 Aug 202318.44%26.8810-Q filed, results (8-K)
31 Aug 202319.26%32.54
15 Sep 202319.25%32.87
29 Sep 202320.63%27.94
13 Oct 202320.91%23.27
31 Oct 202320.46%9.13
15 Nov 202320.24%20.7410-Q filed, results (8-K)
30 Nov 202320.49%18.42
15 Dec 202320.47%15.11
29 Dec 202320.62%16.20

See also: Omeros Corporation's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.